NCT00101270 2013-06-05
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
National Cancer Institute (NCI)
Phase 1 Completed
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
Gustave Roussy, Cancer Campus, Grand Paris